Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Active Matrix Metalloproteinase-8 (aMMP-8) Chair-side Test in Different Periodontal Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03527901
Recruitment Status : Completed
First Posted : May 17, 2018
Last Update Posted : May 17, 2018
Sponsor:
Information provided by (Responsible Party):
Veli Özgen Öztürk, Aydin Adnan Menderes University

Brief Summary:
The aim of this study to evaluate the diagnostic accuracy of a new qualitative aMMP-8 POC test in different periodontal health and disease and as compared to the established quantitative laboratory method (ELISA)

Condition or disease Intervention/treatment
Periodontal Diseases Diagnostic Test: GCF collection with aMMP-8 chair side test Other: Saliva collection

Detailed Description:
MMP-8 has been reported to reflect the inflammatory status in periodontal tissues and, therefore represent as potential biomarkers of periodontitis. A positive aMMP-8 test could be an early indicator of these excessive and undesired tissue reactions.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 103 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 12 Months
Official Title: Evaluation of Active Matrix Metalloproteinase-8 (aMMP-8) Chair-side Test in Different Periodontal Disease and Healthy Implants
Actual Study Start Date : March 1, 2015
Actual Primary Completion Date : March 1, 2016
Actual Study Completion Date : June 1, 2016

Group/Cohort Intervention/treatment
Chronic periodontitis
This groups participant has radiographically moderate alveolar bone loss, CAL > 5 mm and PD >6 mm in several sites of each quadrant
Diagnostic Test: GCF collection with aMMP-8 chair side test
Other: Saliva collection
Generalized aggressive periodontitis
This demonstrated a generalized pattern of severe breakdown and CAL > 5 mm and PD > 6 mm on 8 > teeth; minimum three of those were other than first incisors or first molars
Diagnostic Test: GCF collection with aMMP-8 chair side test
Other: Saliva collection
Gingivitis
This group has varying degrees of gingival inflammation, with CAL < 2 mm, without any radiographical bone loss due to periodontitis
Diagnostic Test: GCF collection with aMMP-8 chair side test
Other: Saliva collection
Implant
Implants classified PD < 5 mm, no bleeding on probing, no suppuration and no radiographic bone loss > 0.5 mm
Diagnostic Test: GCF collection with aMMP-8 chair side test
Other: Saliva collection
Health
Probing depth (PD) < 3mm, no gingival recession due to periodontal disease, and clinical attachment level (CAL) < 2 mm, BOP in < 10% of full-mouth score examination
Diagnostic Test: GCF collection with aMMP-8 chair side test
Other: Saliva collection



Primary Outcome Measures :
  1. aMMP-8 levels of GCF [ Time Frame: 2 hours ]
    GCF levels measured by IFMA


Secondary Outcome Measures :
  1. Salivary MMP-8 levels [ Time Frame: 2 hours ]
    Saliva levels measured by IFMA



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
All participants have minimum 20 teeth
Criteria

Inclusion Criteria:

  • Systemically healthy
  • Nonsmokers

Exclusion Criteria:

  • Participants were not included if they had systemic disease such as diabetes, cardiovascular.
  • Participants who took regular medications that could affect of periodontal tissue
  • Participants who received antibiotics less than 10 weeks before the study
Additional Information:

Layout table for additonal information
Responsible Party: Veli Özgen Öztürk, Principal Investigator, Aydin Adnan Menderes University
ClinicalTrials.gov Identifier: NCT03527901    
Other Study ID Numbers: BAP-17/1
First Posted: May 17, 2018    Key Record Dates
Last Update Posted: May 17, 2018
Last Verified: May 2016

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Veli Özgen Öztürk, Aydin Adnan Menderes University:
aggressive periodontitis
healthy peri-implant
chairside test
chronic periodontitis
Additional relevant MeSH terms:
Layout table for MeSH terms
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases